HUVECa2
The goal of this study was to identify differentially expressed genes in human umbilical vein endothelial cells (HUVEC) in response to soluble TREM2 (sTREM2) treatment. HUVEC cells were purchased from ATCC and cultured under standard endothelial cell conditions. Cells were treated with 500 ng/mL of recombinant human sTREM2 protein for 24 hours. The control group was treated with an equal volume of PBS vehicle.